SBI Healthcare Opportunities Fund vs Nippon India Pharma Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹3522 Cr | ₹8161 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 32% | 21% |
Expense Ratio | 1.94 | 1.82 |
Manager | Pradeep Kesavan | Sailesh Raj Bhan |
ISIN Code | INF200K01446 | INF204K01968 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 6.96% | 5.57% |
6 Month | -2.35% | -7.86% |
1 Year | 19.83% | 12.22% |
3 Year | 22.87% | 18.36% |
5 Year | 29.3% | 27.38% |
SIP Return Analysis
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | -1.91% | -4.43% |
1 Year | 10.16% | -0.48% |
3 Year | 28.36% | 22.66% |
5 Year | 22.98% | 19.18% |
Rolling Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 15.04% | 18.19% |
3 Year | 17.32% | 20.5% |
5 Year | 12.58% | 20.36% |
Risk Management
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 14.597% | 15.623% |
Sharp | 0.987% | 0.707% |
Beta | 0.85% | 0.908% |
Alpha | 4.505% | 0.486% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Pradeep Kesavan | Sailesh Raj Bhan |
Total AUM | ₹434274 Cr | ₹96086 Cr |
Funds Managed | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 6.48 | 1.36 |
Small Cap | 37.63 | 27.14 |
Mid Cap | 28.02 | 32.78 |
Large Cap | 27.87 | 38.72 |
Sector Allocation
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.8 | 1.36 |
Basic Materials | 6.85 | - |
Healthcare | 91.34 | 98.64 |
Top Comparisons
ICICI Prudential Short Term Fund - Growth Option
3Y Returns7.17%
HDFC Short Term Debt Fund - Growth Option
3Y Returns6.81%
Kotak Infrastructure & Economic Reform Fund - Standard Plan-Growth
3Y Returns21.37%
Tata Infrastructure Fund-Regular Plan- Growth Option
3Y Returns19.91%
Mirae Asset Great Consumer Fund - Regular Plan - Growth option
3Y Returns16.04%
UTI India Consumer Fund - Regular Plan - Growth Option
3Y Returns12.09%
Aditya Birla Sun Life Overnight Fund-Regular Plan-Growth
3Y Returns6.18%
LIC MF Overnight Fund Regular - Growth
3Y Returns6.16%